Literature DB >> 9643523

Multiple myeloma: VI International Workshop, June 14-18, 1997, Boston, Massachusetts, USA.

S Bergenbrant1.   

Abstract

The VI International Workshop on Multiple Myeloma was organised by Professor Kenneth C Anderson, Dana Farber Cancer Institute, and held on June 14-18, 1997, in Boston, MA, USA. More than 500 participants from all over the world joined this workshop. Several subjects were introduced and one of the most exciting items of news was the identification of Kaposi's sarcoma-associated herpes virus in the bone marrow stromal cells of patients with MM. The aim of this overview is to give a glimpse of the subjects discussed and the statements made.

Entities:  

Mesh:

Year:  1998        PMID: 9643523     DOI: 10.1007/bf02787337

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  32 in total

1.  Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients.

Authors:  M B Rettig; H J Ma; R A Vescio; M Põld; G Schiller; D Belson; A Savage; C Nishikubo; C Wu; J Fraser; J W Said; J R Berenson
Journal:  Science       Date:  1997-06-20       Impact factor: 47.728

2.  DNA vaccination as cancer immunotherapy.

Authors:  D Zhu; M B Spellerberg; A Thompsett; C A King; T J Hamblin; F K Stevenson
Journal:  Biochem Soc Trans       Date:  1997-05       Impact factor: 5.407

3.  Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizer.

Authors:  S E Salmon; W S Dalton; T M Grogan; P Plezia; M Lehnert; D J Roe; T P Miller
Journal:  Blood       Date:  1991-07-01       Impact factor: 22.113

4.  Sensitivity of multiple myeloma to imexon in the human tumor cloning assay.

Authors:  S E Salmon; E M Hersh
Journal:  J Natl Cancer Inst       Date:  1994-02-02       Impact factor: 13.506

Review 5.  Idiotype-specific T cells in multiple myeloma: targets for an immunotherapeutic intervention?

Authors:  Q Yi; A Osterborg
Journal:  Med Oncol       Date:  1996-03       Impact factor: 3.064

6.  Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells.

Authors:  S S Sahota; R Leo; T J Hamblin; F K Stevenson
Journal:  Blood       Date:  1997-01-01       Impact factor: 22.113

7.  Idiotype-specific T lymphocytes in monoclonal gammopathies: evidence for the presence of CD4+ and CD8+ subsets.

Authors:  Q Yi; I Eriksson; W He; G Holm; H Mellstedt; A Osterborg
Journal:  Br J Haematol       Date:  1997-02       Impact factor: 6.998

8.  Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell.

Authors:  M H Bakkus; I Van Riet; B Van Camp; K Thielemans
Journal:  Br J Haematol       Date:  1994-05       Impact factor: 6.998

9.  Idiotype-specific T cells in multiple myeloma stage I: an evaluation by four different functional tests.

Authors:  A Osterborg; Q Yi; S Bergenbrant; G Holm; A K Lefvert; H Mellstedt
Journal:  Br J Haematol       Date:  1995-01       Impact factor: 6.998

10.  Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes.

Authors:  B Dubois; B Vanbervliet; J Fayette; C Massacrier; C Van Kooten; F Brière; J Banchereau; C Caux
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.